Abstract
Photodynamic therapy (PDT) is a light-catalyzed process that can initiate cellular death pathways from the formation of cytotoxic reactive oxygen species at sub-cellular sites. Apoptosis was the first such pathway to be identified. Autophagy can also occur and is often found to be cytoprotective. Another process termed paraptosis can also have lethal consequences, even in cells with an impaired apoptotic pathway. PDT in vivo can evoke other potentially cytotoxic processes including vascular shutdown and enhanced immunologic recognition of neoplastic cells. Using appropriate photosensitizing agents, sub-cellular PDT targeting can be directed so that the resulting interplay among assorted death and survival pathways will result in an enhanced level of photokilling.
Similar content being viewed by others
References
Raab O (1900) Über die Wirkung fluoreszierender Stoffe auf Infusorien. Z Biol 39:524–546
Lipson RL, Baldes EJ, Olsen AM (1961) Hematoporphyrin derivative: a new aid for endoscopic detection of malignant disease. J Thorac Cardiovasc Surg 42:623–629
Lipson RL, Baldes EJ, Olsen AM (1961) The use of a derivative of hematoporphyrin in tumor detection. J Natl Cancer Inst 26:1–11
Dougherty TJ, Grindey GB, Fiel R, Weishaupt KR, Boyle DG (1975) Photoradiation therapy. II. Cure of animal tumors with hematoporphyrin and light. J Natl Cancer Inst 55:115–121
Dougherty TJ, Kaufman JE, Goldfarb A, Weishaupt KR, Boyle D, Mittleman A (1978) Photoradiation therapy for the treatment of malignant tumors. Cancer Res 38:2628–2635
Dougherty TJ, Gomer CJ, Henderson BW, Jori G, Kessel D, Korbelik M, Moan J, Peng Q (1998) Photodynamic therapy. J Natl Cancer Inst 90:889–905
Agostinis P, Berg K, Cengel K, Foster TH, Girotti AW, Gollnick SO, Hahn SM, Hamblin MR, Juzeniene A, Kessel D, Korbelik M, Moan J, Mroz P, Nowis D, Piette J, Wilson BC, Golab J (2011) Photodynamic therapy of cancer: an update. CA Cancer J Clin 61:250–281
Dolmans DE, Fukumura D, Jain RK (2003) Photodynamic therapy for cancer. Nat Rev Cancer 3:380–387
Solban N, Rizvi I, Hasan T (2006) Targeted photodynamic therapy. Lasers Surg Med 38:522–531
Robertson CA, Evans DH, Abrahamse H (2009) Photodynamic therapy (PDT): a short review on cellular mechanisms and cancer research applications for PDT. J Photochem Photobiol B 96:1–8
Mroz P, Yaroslavsky A, Kharkwal GB, Hamblin MR (2011) Cell death pathways in photodynamic therapy of cancer. Cancers (Basel 3:2516–2539
Agarwal ML, Clay ME, Harvey EJ, Evans HH, Antunez AR, Oleinick NL (1991) Photodynamic therapy induces rapid cell death by apoptosis in L5178Y mouse lymphoma cells. Cancer Res 51:5993–5996
Weishaupt KR, Gomer CJ, Dougherty TJ (1976) Identification of singlet oxygen as the cytotoxic agent in photoinactivation of a murine tumor. Cancer Res 36:2326–2329
Sharman WM, Allen CM, van Lier JE (2000) Role of activated oxygen species in photodynamic therapy. Methods Enzymol 319:376–400
Reiners JJ Jr, Agostinis P, Berg K, Oleinick NL, Kessel D (2010) Assessing autophagy in the context of photodynamic therapy. Autophagy 6:7–18
Sperandio S, de Belle I, Bredesen DE (2000) An alternative, nonapoptotic form of programmed cell death. Proc Natl Acad Sci USA 97:14376–14381
Kessel D (2019) Apoptosis, paraptosis and autophagy: death and survival pathways associated with photodynamic therapy. Photochem Photobiol 95:119–125
Liu X, Kim CN, Yang J, Jemmerson R, Wang X (1996) Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell 86:147–157
Kessel D, Luo Y (1999) Photodynamic therapy: a mitochondrial inducer of apoptosis. Cell Death Differ 6:28–35
Kim HR, Luo Y, Li G, Kessel D (1999) Enhanced apoptotic response to photodynamic therapy after bcl-2 transfection. Cancer Res 59:3429–3432
Korsmeyer SJ, Wei MC, Salto M, Weiler S, Oh KJ, Schlesinger PH (2000) Proapoptotic cascade activated BID, which oligomerizes BAK or BAX into pores that result in the release of cytochrome c. Cell Death Differ 7:1166–1173
Stoka V, Turk B, Schendel SL, Kim T-H, Cirman T, Snipas SJ, Ellerby LM, Bredesen D, Freeze H, Abrahamson M, Bromme D, Krajewski S, Reed JC, Yin X-M, Turk V, Salvesen GS (2001) Lysosomal protease pathways to apoptosis: cleavage of Bid, not pro-caspases, is the most likely route. J Biol Chem 276:3149–3157
Reiners JJ Jr, Caruso JA, Mathieu P, Chelladurai B, Yin XM, Kessel D (2002) Release of cytochrome c and activation of pro-caspase-9 following lysosomal photodamage involves Bid cleavage. Cell Death Differ 9:934–944
Parzych KR, Klionsky DJ (2014) Overview of autophagy: morphology, mechanism, and regulation. Antioxid Redox Signal 20:460–473
Andrzejak M, Price M, Kessel DH (2011) Apoptotic and autophagic responses to photodynamic therapy in 1c1c7 murine hepatoma cells. Autophagy 7:979–984
Yousefi S, Perozzo R, Schmid I, Ziemiecki A, Schaffner T, Scapozza L, Brunner T, Simon HU (2006) Calpain-mediated cleavage of Atg5 switches autophagy to apoptosis. Nat Cell Biol 8:1124–1132
Kessel D, Evans CL (2016) Promotion of proapoptotic signals by lysosomal photodamage: mechanistic aspects and influence of autophagy. Photochem Photobiol 92:620–623
Kessel D, Oleinick NL (2018) Cell death pathways associated with photodynamic therapy: an update. Photochem Photobiol 94:213–218
Kessel DH, Price M, Reiners JJ Jr (2012) ATG7 deficiency suppresses apoptosis and cell death induced by lysosomal photodamage. Autophagy 8:1333–1341
Pierroz V, Rubbiani R, Gentili C, Patra M, Mari C, Gasser G, Ferrari S (2016) Dual mode of cell death upon the photo-irradiation of a RuII polypyridyl complex in interphase or mitosis. Chem Sci 7:6115–6124
Kessel D, Cho WJ, Rakowski J, Kim HE, Kim HC (2020) Effects of HPV status on responsiveness to ionizing radiation vs photodynamic therapy in head and neck cancer cell lines. Photochem Photobiol. https://doi.org/10.1111/php.13150
Sperandio S, Poksay K, de Belle I, Lafuente MJ, Liu B, Nasir J, Bredesen DE (2004) Paraptosis: mediation by MAP kinases and inhibition by AIP-1.Alix. Cell Death Differ 11:1066–1075
Kessel D (2019) Pathways to paraptosis after ER photodamage in OVCAR-5 cells. Photochem Photobiol 95:1239–1242
Henderson BW, Waldow SM. Mang TS, Potter WR, Malone PB, Dougherty TJ (1985) Tumor destruction and kinetics of tumor cell death in two experimental mouse tumors following photodynamic therapy. Cancer Res 45:572–576
Wieman T, Mang TS, Fingar VH, Hill TG, Reed MW, Corey TS, Nguyen VQ, Render ER (1988) Effect of photodynamic therapy on blood flow in normal and tumor vessels. Surgery 104:512–517
Castano AP, Mroz P, Hamblin MR (2006) Photodynamic therapy and anti-tumour immunity. Nat Rev Cancer 6:535–545
Garg AD, Agostinis P (2014) ER stress, autophagy and immunogenic cell death in photodynamic therapy-induced anti-cancer immune responses. Photochem Photobiol Sci 13:474–487
Li W, Yang J, Luo L, Jiang M, Qin B, Yin H, Zhu C, Yuan X, Zhang J, Luo Z, Du Y, Li Q, Lou Y, Qiu Y, You J (2019) Targeting photodynamic and photothermal therapy to the endoplasmic reticulum enhances immunogenic cancer cell death. Nat Commun 26:3349
Noweski A, Roosen A, Lebdai S, Barret E, Emberton M, Benzaghou F, Apfelbeck M, Gaillac B, Gratzke C, Stief C, Azzouzi AR (2019) Medium-term follow-up of vascular-targeted photodynamic therapy of localized prostate cancer using TOOKAD soluble WST-11 (Phase II Trials). Eur Urol Focus 5:1022–1028
Wilson BC (1989) Photodynamic therapy: light delivery and dosage for second-generation photosensitizers. In: Photosensitizing compounds: their chemistry, biology clinical use; Ciba Found Symp, pp 60–73
Cincotta L, Szeto D, Lampros E, Hasan T, Cincotta AH (1996) Benzophenothiazine and benzoporphyrin derivative combination phototherapy effectively eradicates large murine sarcomas. Photochem Photobiol 63:229–237
Kessel D (2017) Subcellular targeting as a determinant of the efficacy of photodynamic therapy. Photochem Photobiol 93:609–612
Schmidt-Erfurth U, Miller J, Sickenberg M, Bunse A, Laqua H, Gragoudas E, Zografos L, Birngruber R, van den Bergh H, Strong A (1998) Photodynamic therapy of subfoveal choroidal neovascularization: clinical and angiographic examples. Graefe’s Arch Clin Exp Ophthalmol 236:365–374
Kessel D, Reiners JJ (2017) Effects of combined lysosomal and mitochondrial photodamage in a non-small-cell lung cancer cell line: The role of paraptosis. Photochem Photobiol 93:1502–1509
Obaid G, Jin W, Bano S, Kessel D, Hasan T (2019) Lipid formulations of benzoporphyrin derivative: exploring the dependence of nanoconstruct photophysics and photochemistry on their therapeutic index in ovarian cancer cells. Photochem Photobiol 95:364–377
Rizvi I, Obaid G, Bano S, Hasan T, Kessel D (2018) Photodynamic therapy: promoting in vitro efficacy of photodynamic therapy by liposomal formulations of a photosensitizing agent. Lasers Surg Med 50:499–505
Rizvi I, Nath S, Obaid G, Ruhi MK, Moore K, Bano S, Kessel D, Hasan T (2019) A Combination of visudyne and a lipid-anchored liposomal formulation of benzoporphyrin derivative enhances photodynamic therapy efficacy in a 3D model for ovarian cancer. Photochem Photobiol 95:419–429
Gomer CJ, Dougherty TJ (1979) Determination of [3H]- and [14C]hematoporphyrin derivative distribution in malignant and normal tissue. Cancer Res 39:146–151
Sharkey SM, Wilson BC, Moorehead R, Singh G (1993) Mitochondrial alterations in photodynamic therapy-resistant cells. Cancer Res 53:4994–4999
Olsen CE, Weyergang A, Edwards VT, Berg K, Brech A, Weisheit S, Høgset A, Selbo PK (2017) Development of resistance to photodynamic therapy (PDT) in human breast cancer cells is photosensitizer-dependent: possible mechanisms and approaches for overcoming PDT-resistance. Biochem Pharmacol 144:63–77
Casas A, Di Venosa G, Hasan T, Batlle A (2011) Mechanisms of resistance to photodynamic therapy. Curr Med Chem 18:2486–2515
Baglo Y, Liang BJ, Robey RW, Ambudkar SV, Gottesman MM, Huang HC (2019) Porphyrin-lipid assemblies and nanovesicles overcome ABC transporter-mediated photodynamic therapy resistance in cancer cells. Cancer Lett 457:110–118
Kessel D (2020) Hypericin accumulation as a determinant of PDT efficacy. Photochem Photobiol. https://doi.org/10.1111/php.13302
Zhu T, Shi L, Yu C, Dong Y, Qiu F, Shen L, Qian Q, Zhou G, Zhu X (2019) Ferroptosis promotes photodynamic therapy: supramolecular photosensitizer-inducer nanodrug for enhanced cancer treatment. Theranostics 9:3293–3307
Turubanova VD, Balalaeva IV, Mishchenko TA, Catanzaro E, Alzeibak R, Peskova NN, Efimova I, Bachert C, Mitroshina EV, Krysko O, Vedunova MV, Krysko DV (2019) Immunogenic cell death induced by a new photodynamic therapy based on photosens and photodithazine. J Immunother Cancer 7:350
Miki Y, Akimoto J, Moritake K, Hironaka C, Fujiwara Y (2015) Photodynamic therapy using talaporfin sodium induces concentration-dependent programmed necroptosis in human glioblastoma T98G cells. Lasers Med Sci 30:1739–1745
Li W, Yang J, Luo L, Jiang M, Qin B, Yin H, Zhu C, Yuan X, Zhang J, Luo Z, Du Y, Li Q, Lou Y, Qiu Y, You J (2019) Targeting photodynamic and photothermal therapy to the endoplasmic reticulum enhances immunogenic cancer cell death. Nat Commun 10:3349
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Kessel, D. Photodynamic therapy: apoptosis, paraptosis and beyond. Apoptosis 25, 611–615 (2020). https://doi.org/10.1007/s10495-020-01634-0
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10495-020-01634-0